| Patents for C12R 1 - Micro-organisms (92,025) |
|---|
| 04/15/2004 | US20040072310 Enzymatic resolution of aryl and thio-substituted acids |
| 04/15/2004 | US20040072306 Method for producing d-pantothenic acid and/or salts thereof as an additive for animal feed |
| 04/15/2004 | US20040072303 Method of preparing a guanosine-group compound and an intermediate thereof |
| 04/15/2004 | US20040072300 Comprises expression vector coding cytokines/immunoglobulin fusion protein for treating tumor and autoimmune disorders; immunotherapy; antitumor agents |
| 04/15/2004 | US20040072239 Method for controlling the microbiological quality of an aqueous medium and kit therefor |
| 04/15/2004 | US20040072229 Comprises nucleotide sequences coding ligand binding membrane protein for identifying modulator for treatment of kidney, neural, pancreatic or prostate diseases |
| 04/15/2004 | US20040072178 Genes encoding proteins capable of regenerating luciferin, recombinant dna and process for producng protein capable of regenerating luciferin |
| 04/15/2004 | US20040072159 Bzip type transcription factors regulating the expression of rice storage protein |
| 04/15/2004 | US20040072155 Molecular methods for detecting guar gum additions to locust bean gum |
| 04/15/2004 | US20040072151 Method of extracting virus genes and extraction apparatus |
| 04/15/2004 | US20040071737 Polysaccharides and/or glycopeptides preparable from keratinophilic fungi and yeasts; vaccines, immunomodulators, and antiallergens; precipitation and separation of supernatant; treatment with mineral or organic acid |
| 04/15/2004 | US20040071712 Modified peptides as therapeutic agents |
| 04/15/2004 | US20040071693 Humanised antibodies |
| 04/15/2004 | US20040071692 Minimizes toxicity to normal tissue; high therapeutic index |
| 04/15/2004 | US20040071676 Yeast expression vector and a method of making a recombinant protein by expression in a yeast cell |
| 04/15/2004 | CA2498337A1 Hydroxyphenylundecane derivatives, a process for their production and their use |
| 04/14/2004 | EP1408334A1 Procalcitonin 3-116 |
| 04/14/2004 | EP1408123A1 A microorganism in which the fadR gene is knocked out and a process for producing L-threonine using the microorganism |
| 04/14/2004 | EP1408118A1 Enzymatic method of producing 4-0-b-d galactopyranosyl-d-xylose, 4-0-b-d-galactopyranosyl-d-xylose obtained using said method, compositions containing same and the use thereof in evaluating intestinal lactase |
| 04/14/2004 | EP1407054A2 Expression system |
| 04/14/2004 | EP1406997A2 A mouse unable to express functional alpha-4 integrin protein, and methods for assaying compounds or agents for alpha-4 integrin protein antagonist activity and a genetic marker for evaluating efficacy of modulators of signaling activity of a vla-4 receptor |
| 04/14/2004 | EP1181038B1 Novel indications of mannan-binding lectin (mbl) in the treatment of immunocompromised individuals |
| 04/14/2004 | EP1177314B1 Assays for nucleoside diphosphates and triphospates |
| 04/14/2004 | EP0876493B1 Production of bacillus thuringiensis integrants |
| 04/14/2004 | EP0870044B1 Regulated protein expression in stably transfected mammalian cells |
| 04/14/2004 | EP0707487B1 Methods and pharmaceutical compositions useful for treating neurological disorders |
| 04/14/2004 | EP0531372B2 A cellulase preparation comprising an endoglucanase enzyme |
| 04/14/2004 | CN1489629A MIcrobiological method for producing L-carnitine |
| 04/14/2004 | CN1488759A Method for producing lactic acid from paper-making pulp |
| 04/14/2004 | CN1145798C In vitro method for determining presence of hepatocellular carcindoma |
| 04/14/2004 | CN1145703C Process for fermentative production of deacylated cephaloporins |
| 04/14/2004 | CN1145699C Phenylacetyl-CoA ligase from penicillium chrysogenum |
| 04/14/2004 | CN1145698C Synthetic insecticide crystalline protein gene |
| 04/14/2004 | CN1145696C Antifungal proteins |
| 04/14/2004 | CN1145692C Hypersensitive response induced resistance in plants by seed treatment |
| 04/13/2004 | US6720014 Culturing escherichia coli; genetic engineering and expression |
| 04/13/2004 | US6719986 Fermented by microorganisms; skin disorders; aging and wrinkle resistance |
| 04/13/2004 | US6719971 Method for making humanized antibodies |
| 04/13/2004 | US6719968 For therapy of tendinitis, or other tendon or ligament defect |
| 04/13/2004 | CA2291608C Neurotrophic factor receptors |
| 04/13/2004 | CA2195076C Process for modifying the stability of antibodies |
| 04/13/2004 | CA2090953C High pullulan content product, and its preparation and uses |
| 04/08/2004 | WO2004029270A2 Process for producing vitamin b6 |
| 04/08/2004 | WO2003104473A8 Galactosyl isomalt, method for production and use thereof |
| 04/08/2004 | WO2003100087A3 Regulation of novel human asparagine-hydroxylases |
| 04/08/2004 | WO2003092600A3 Site specific listeria integration vectors and methods for using the same |
| 04/08/2004 | WO2003092578A3 Further syntheses of cyproterone acetate |
| 04/08/2004 | WO2003087386A3 Methods for producing sulphurous fine chemicals by fermentation using meth-coding coryneform bacteria |
| 04/08/2004 | WO2003053158A9 Malleable protein matrix and uses thereof |
| 04/08/2004 | US20040067940 Antiischemic agents; antiinflammatory agents; antiallergens; autoimmune disease |
| 04/08/2004 | US20040067879 Effective against fungi such as Candida parapsilosis, Candida albicans, Cryptococcus neoformans, and/or Histoplasma capsulatum |
| 04/08/2004 | US20040067576 Polyhydroxyalkanoate, method for production thereof and microorganisms for use in the same |
| 04/08/2004 | US20040067558 Used as a raw material of an anti-virus agent, antisense medicine |
| 04/08/2004 | US20040067555 Recombinant hosts suitable for simultaneous saccharification and fermentation |
| 04/08/2004 | US20040067550 Method for the production of beta-carotene |
| 04/08/2004 | US20040067500 Compositions and methods relating to the peroxisomal proliferator activated receptor-alpha mediated pathway |
| 04/08/2004 | DE10244811A1 Verfahren zur Herstellung von 3-Heteroaryl-3-hydroxy-propansäurederivaten A process for the preparation of 3-heteroaryl-3-hydroxy-propanoic acid derivatives |
| 04/07/2004 | EP1405917A2 Process for the production of 3-Heteroaryl-3-hydroxy-propionic acid derivatives by enantioselective microbial reduction |
| 04/07/2004 | EP1405914A1 Nucleic acid sequences and expression systems for heparinase II and heparinase III derived from flavobacterium heparinum |
| 04/07/2004 | EP1405913A2 Process for improving the production of 5R clavams |
| 04/07/2004 | EP1405864A1 Process for decreasing the reducing sugars content of light steepwater |
| 04/07/2004 | EP1404852A1 Expression of genes in modified vaccinia virus ankara by using the cowpox ati promoter |
| 04/07/2004 | EP1404851A2 Production of proteins in plants |
| 04/07/2004 | EP1404846A1 Method for obtaining cells with new properties |
| 04/07/2004 | EP1404829A1 Novel aminopeptidase derived from bacillus licheniformis, gene encoding the aminopeptidase, expression vector containing the gene, transformant and method for preparation thereof |
| 04/07/2004 | EP1404812A1 Dopaminergic neurons and proliferation-competent precursor cells for treating parkinson's disease |
| 04/07/2004 | EP1404706A2 Mycobacterial antigens expressed during latency |
| 04/07/2004 | EP1123384B1 Use of compositions depleted of dendritic cells for improving allogeneic hematopoietic cell transplantation |
| 04/07/2004 | EP0854914B1 Live vaccines against gram-negative pathogens, expressing heterologous o-antigens |
| 04/07/2004 | EP0587791B1 Enhancement of expression by gene targeting in endogenous retrovirus-like sequences |
| 04/07/2004 | CN1487997A Gene HD3A inducing flowering of plant and utilization thereof |
| 04/07/2004 | CN1487079A Fermentation production process for phosphoglyceric acid family amino-acid and amino-acid derivative |
| 04/07/2004 | CN1144875C OMP 26 antigen of haemophilus influenzae |
| 04/07/2004 | CN1144874C Production of enzymatically active recombinant carboxypeptidase B |
| 04/07/2004 | CN1144816C Novel antproliferative protein from bacillus thuringiensis var. Thuringiensis |
| 04/07/2004 | CN1144815C Modified i CE.(oli) enterotoxin II signal peptide and microorganism expressing fusion protein of said peptide and heterologous protein |
| 04/06/2004 | US6716612 Modifying the branching degree of amylopectin synthesized in plants, |
| 04/06/2004 | US6716609 Enzymatic polypeptide for use in the generation of 2-pyrone-4,6-dicarboxylic acid |
| 04/06/2004 | US6716602 Metabolic rate shifts in fermentations expressing recombinant proteins |
| 04/06/2004 | US6716601 Controlling the expression of homologous and heterologous nucleic acid molecules in yeast cells. |
| 04/06/2004 | US6716587 Antiinflammatory |
| 04/06/2004 | CA2196296C Production of tissue factor pathway inhibitor |
| 04/06/2004 | CA2194685C A method of improving the quality of plant seeds |
| 04/06/2004 | CA2147372C Multidrug resistance gene |
| 04/06/2004 | CA2085232C Xylanase production |
| 04/06/2004 | CA2042016C Recombinant polypeptides and peptides, nucleic acids coding for the same and use of these polypeptides and peptides in the diagnostic of tuberculosis |
| 04/03/2004 | CA2453071A1 Genes and proteins for the production of polyene polyketides |
| 04/01/2004 | WO2003077868A3 Synthesis of synthons for the manufacture of bioactive compounds |
| 04/01/2004 | US20040064842 Using dispersed regulatory nucleotide sequences to regulate transcription in animal cells, tissues and/or organs; gene expression inhibition |
| 04/01/2004 | US20040063908 Comprises genetically engineered hemophilus adherence and penetration (HAP) proteins for treatment and prevention of influenza; immunotherapy |
| 04/01/2004 | US20040063192 Using sulfur dioxide to decrease concentration of carbon dioxide and ethanol produced in industrial steeping process |
| 04/01/2004 | US20040063180 Comprises nucleotide sequences coding lysine biosynthetic polypeptide for transforming coryneform bacteria and fermentation of lysine; animal feeds and medicine |
| 04/01/2004 | US20040063171 Genetic engineered microroganisms; auxotropic mutants; polynucleotide sequences |
| 04/01/2004 | US20040063155 Using subtilisin to target preferential nucleotide sequences and diagnose viral and parasitic infections |
| 04/01/2004 | US20040063097 Nanomachine compositions and methods of use |
| 04/01/2004 | US20040062825 Remedies for allergic diseases and process for producing the same |
| 04/01/2004 | US20040062811 Polyhydroxyalkonoate and method of producing same, and w-(2-thienylsulfanyl) alkanoic acid and method of producing same |
| 04/01/2004 | US20040062752 Genetic engineered polynucleotide; antihemophilic factor; in situ administering to liver |
| 03/31/2004 | EP1403377A1 Consensus phytases |
| 03/31/2004 | EP1403376A2 Expression of heterologous genes according to a targeted expression profile |